CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis 期刊论文
2019, 卷号: 11, 页码: 4699-4706
作者:  Han, Yiqun;  Wang, Jiayu;  Liu, Weiming;  Yuan, Peng;  Li, Qing
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Relationship between Ki67 and the efficacy of neoadjuvant chemotherapy: clinicopathological characteristics of luminal B breast cancer 期刊论文
2019, 卷号: 12, 期号: 5, 页码: 6044-6048
作者:  Wang, Jiayu;  Sang, Die;  Xu, Binghe;  Yuan, Peng;  Ma, Fei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li Qiao;  Guan Xiuwen;  Chen Shanshan;  Yi Zongbi;  Lan Bo
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis 期刊论文
2019, 卷号: 173, 期号: 2, 页码: 487
作者:  Wang Jiayu;  Xu Binghe;  Wang Wenna;  Zhai Xiaoyu;  Chen Xuelian
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China 期刊论文
2019, 卷号: 19, 期号: 2, 页码: E370-E375
作者:  Lan, Bo;  Ma, Fei;  Han, Mei;  Chen, Shanshan;  Wang, Wenna
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 1
作者:  Guan, Xiuwen;  Ma, Fei;  Li, Chunxiao;  Wu, Shiyang;  Hu, Shangying
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis (vol 171, pg 535, 2018) 期刊论文
2019, 卷号: 173, 期号: 2, 页码: 487-487
作者:  Wang, Jiayu;  Xu, Binghe;  Wang, Wenna;  Zhai, Xiaoyu;  Chen, Xuelian
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Phase I safety and pharmacokinetic study of cipatinib, an original dual tyrosine kinase inhibitor 期刊论文
2018, 卷号: 9, 期号: 8, 页码: 1041-1047
作者:  Wang, Jiayu;  Han, Yiqun;  Shi, Xiuqing;  Li, Qing;  Zhang, Pin
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
TNM stage at diagnosis is more predictive of prognosis than pathological complete response in young breast cancer treated with neoadjuvant chemotherapy 期刊论文
2018, 卷号: 29, 期号: 2, 页码: 176-183
作者:  Wang, Jingjing;  Li, Qing;  Zhang, Pin;  Yuan, Peng;  Ma, Fei
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer 期刊论文
2018, 卷号: 9, 期号: 5, 页码: 613-620
作者:  Zhai, Xiaoyu;  Hong, Ruoxi;  Fan, Ying;  Yuan, Peng;  Wang, Jiayu
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace